Purpose. To investigate microrobots as an assistive tool for minimally invasive intraocular surgery and to demonstrate mobility and controllability inside the living rabbit eye.
Introduction
With the advent of modern ophthalmic devices such as 23 G and 25 G tools, ophthalmology is moving towards more minimally invasive surgery, resulting in less inflammation, decreased operating times and less damage to the conjunctiva 1 . In order to further the advantages of minimally invasive ophthalmic surgery, several researchers are developing smart miniature tools or robot-assisted devices that assist in ocular surgery and help overcome the limits of human performance due to their high precision 2, 3, 4, 5, 6 . Here we describe a microrobotic approach for minimally invasive surgery in the posterior eye segment as a future treatment for various ocular impairments and present results of in vivo mobility experiments of wirelessly controlled devices 285 µm diameter and 1800 µm length in lapine eyes. The small devices that we call "microrobots" are injected into the vitreous cavity through a small incision in the pars plana region of the sclera and can be guided wirelessly to the pathological site where they are operated by a surgeon to perform a required treatment such as mechanical manipulation or targeted drug delivery.
The first use of a device of this type will be for directing intravitreal inserts near pathological sites on the retina in order to reduce the volume of drug required for treatment, thus extending the length of time for which the insert can provide a therapeutically relevant dose. While topical administration is most commonly used to treat ocular disorders, the physiological barriers to topical absorption are considerable. High administration frequency and high drug doses are required 7 , because only a small fraction (approximately 1 to 10%) of the topically applied drug permeates the eye 8 . Therefore, macular diseases are frequently administered by intravitreal injections, predominantly using anti-VEGF (vascular endothelial growth factor) agents 9 . Intravitreal administration is superior to topical administration and systemic drug delivery, where toxic side effects to non-targeted tissue can occur due to high doses 7, 10 .
Intravitreal inserts are used for single injection, long-term drug delivery. These devices can be loaded with a variety of drugs targeting a broad range of ocular diseases. A pellet device comprising a silicone shell has been developed to release therapeutic intraocular doses of thalidomide and could be used for the treatment of subretinal neovascularization 11 . Several non-bioerodible inserts have been suggested, which are loaded with ocular corticosteroid fluocinolone acetonide for the treatment of chronic, non-infectious uveitis, and have exhibited stable drug release over a period of approximately three months 11 . Ozurdex TM , a biodegradable intravitreal implant, is approved as a first-line treatment for RVO 12 . These ocular inserts lack the ability to move and, therefore, cannot be safely directed to a pathological site within the eye. Additionally, the removal of some of these devices requires a vitrectomy, which bears risks of complications. The addition of mobility to intravitreal devices to guide them to the diseased area will allow much slower release drug delivery while providing an equivalent dosage to the pathology due to the nonlinear nature of Fick's law of diffusion. 
Materials and Methods

Intraocular Microrobot
Figure 1(a) shows a microrobot, which is injected, into the posterior section of the eye through the pars plana region of the sclera. The microrobot is wirelessly controlled and can be removed by a magnetic tool. The soft-magnetic microrobot has the shape of a hollow cylinder with outer diameter of 285 µm and inner diameter of 125 µm; its length is 1800 µm. The outer diameter is chosen such that the microrobot fits a 23 G needle, as shown in Figure 1 (b). The microrobot is rendered non-toxic using polypyrrole or inert metallic coatings, which have been tested for cell viability by Sivaraman et al.
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and customized fabrication methods allow for high flexibility in diameter, length and magnetic volume 21, 22 . 
Porcine Eyes (ex vivo)
It has been suggested that the viscoelastic behavior of the central vitreous region of a pig closely resembles that of the central vitreous region of a human eye in terms of rheological parameters 26 . The same study reports that the anterior and posterior regions of the porcine vitreous resemble a dense gel, whereas the human vitreous has a thinner and in some cases aqueous consistency. Similarly, it has been observed, that human vitreous undergoes liquefaction with increasing age 27 . It can be concluded that, with respect to the properties of the vitreous humor, porcine eyes act as a stiff model of the human eye.
In order to account for the rapid loss of hyaluronic acid of the vitreous upon removal from the eye globe and to sustain the intraocular pressure (IOP), microrobotic mobility experiments are conducted inside the eye globe without destroying the natural structure of the eye. Ex vivo experiments in porcine cadaver eyes are performed one hour post mortem.
Lapine Eyes (in vivo)
In order to evaluate the ability of intravitreal microrobots to move in the living eye, in vivo mobility experiments were conducted in rabbits. Due to their characteristic bright red eyes, the New Zealand white rabbit breed (9 month-old females) was chosen for this study. Experiments are undertaken in five individual rabbit eyes, three of which are vitrectomized. One eye is subsequently filled with BSS and two with silicone oil (AK 1000). The rabbit is anesthetized and its head is placed inside the workspace of the OctoMag, such that the studied eye is located in its center, as illustrated in Figure 3 .
The protocols concerning animal housing, treatment and monitoring were approved by the Swiss Veterinary Office according to the Swiss decree on animal protection 28 and adhere to the ARVO guidelines for animal experiments. This study was undertaken in cooperation with ophthalmologists from the University Hospital Bern and the Veterinary Hospital Zurich. 
Mobility Experiments
A microrobot is injected into the central vitreous humor of the porcine or lapine eyes with a syringe equipped with a 23 G needle. After insertion of the microrobot, the eye is placed centrally in the workspace of the OctoMag for experimentation. After experimentation the microdevice is removed from the vitreous cavity using a magnetic tool that is manufactured from a standard syringe. A magnetic wire is inserted into the needle, which attracts the microrobot if a low magnetic field is applied that also orients the device. Subsequently, the microrobot can be pulled into the needle and removed from the eye. Injection and removal of an intraocular microrobot are illustrated in Figure 4 . 
Rotational Mobility
The intraocular microrobot is rotated in the plane, normal to the line of vision in the posterior region of the eye. The rotation of the microrobot is caused by the rotation of the applied magnetic field, In order to evaluate the rotational mobility of an untethered intraocular microrobot and its response to magnetic field strength, the field magnitude is set to 10 mT, 20 mT, 30 mT and 40 mT whereas the field's rotational frequency is held constant at 1 Hz and the intraocular microrobot mobility is recorded. In a second series of experiments, the rotation of an intraocular microrobot is investigated at constant field magnitude whereas the field rotation frequency is set to 0.05 Hz, 0.1 Hz, 0.5 Hz, 1 Hz and 2 Hz. For experiments in vitreous and silicone oil the field magnitude is held constant at 30 mT. It is set to a lower field magnitude (10 mT) for experiments in BSS due to an unstable response of the microrobot in BSS at higher field strengths.
Translational Mobility
In order to examine the translational mobility of the microrobot inside the eye globe, a magnetic gradient is applied. The microrobot is surrounded by lapine vitreous, BSS or silicone oil in in vivo experiments and porcine vitreous in ex vivo testing. The magnetic field gradient is increased from 0 to 500 mT/m, resulting in translational movement of the intraocular microrobot whereas the field magnitude and orientation are held constant for each experiment. Experiments are undertaken for magnetic field magnitudes of 10 mT, 20 mT, 30 mT and 40 mT. Furthermore, the translational mobility of the microdevice in porcine and lapine vitreous is compared.
Motion Tracking
The microscope equipped with a camera takes consecutive images of the inside of the eye globe with a speed of 15 Hz. In order to track the microrobot movement a script is written in MATLAB, which returns the robot orientation and position in every image. Due to minor movement of the rabbit eye during in vivo experiments, noise occurs and the microrobot position data must be filtered using a moving average filter with window size of ten data points for further analysis.
Results and Discussion
Rotational Movement
As a result of the rotating magnetic field, the intraocular microrobot follows the field with a time delay. It is observed that the plotted angles of rotation show almost no change for different field magnitudes in all four surrounding media. The time delay of the microrobot rotation compared to the field rotation is similar for all recorded field magnitudes at constant frequency in each medium.
Constant Magnetic Field Frequency
Therefore, it is concluded that the magnitude of the rotating magnetic field has no influence on the time delay of the microrobot. Unlike in vitreous, the microrobot shows very unstable movement in BSS at 40 mT (not plotted). This instability of the microrobot can be explained with an increasing magnetic drift inside the OctoMag workspace due to the increasing field strength. Furthermore, the viscosity of BSS is much lower than that of vitreous, thus, less damping of the movement is observed and instabilities are less controllable. In porcine vitreous the microrobot movement is hindered at field strength of 10 mT (not plotted), presumably due to collagen fibers inside the vitreous. As suggested in literature vitreous is not only a viscous fluid, but also has elastic properties 29 , which are observed in some experiments described in this work. Figure 8 shows the corresponding plots for such a case, where the microrobot is unable to accomplish a full rotation due to being caught in collagen fibers. The figure shows an applied magnetic field rotating at a frequency of 0.5 Hz with a magnitude of 30 mT. Figure 9 illustrates consecutive images of this motion behavior of the microrobot.
Constant Magnetic Field Magnitude
Images a) to d) show the intravitreal microrobot at a constant orientation whereas the magnetic field, indicated by a black arrow, changes its angle. When the angle between the magnetic field and the microrobot becomes larger than 90°, the microrobot quickly aligns with the field and, subsequently, starts following the field with a delay until it pauses again. Using a microscope, thin collagen fiber bundles can be observed that are attached to the intravitreal microrobot. Therefore, it is concluded, that the insert is entangled in the elastic fibers, which constrain the microrobot mobility in vitreous. In order to compare the mobility of an intraocular microrobot in different media, Figure 10 summarizes the correlation between the relative time delay of a microrobot in lapine and porcine vitreous, BSS and silicone oil, and the rotation of the magnetic field. The relative delay, defined by the time delay normalized by the period of rotation, is plotted against the period and its frequency in the surrounding media. The figure illustrates that relative time delay decreases with decreasing frequency and thus, increasing period T. 
Translational Movement
The force resulting in the translation of the intraocular microrobot is caused by an applied magnetic field gradient generated by the OctoMag. Figure 11 shows four consecutive images of a wireless microrobot inside the vitrectomized rabbit eye, surrounded by BSS. A magnetic field gradient is applied along the horizontal direction causing the microrobot to translate along this axis. field gradient is observed. However, the translation of the microrobot in vitreous is less than 0.2 mm for a magnetic gradient, that increases piecewise from 0 to 500 mT/m over 20 seconds, as seen in Figure 12 . It is assumed that collagen fiber bundles that attach to the microrobot in vitreous cause the lack of translational movement. The interaction between the microrobot and collagen fiber bundles can be modeled as a mass-spring system. Figure 13 shows the response of a microrobot that is entangled in a collagen fiber bundle within lapine vitreous. Magnetic gradients between 0 and 300 mT/m are applied at a constant field magnitude of 30 mT. It is shown that the applied force is proportional to microrobot displacement. Thus, collagen fiber bundles show the behavior of a linear spring. collagen fibers are present in BSS in that the microrobot can entangle. However, due to the low viscosity of BSS, the microrobot sinks to the retina instead of floating within the central eye. When applying a magnetic field gradient, the microrobot sticks to the retina until a critical gradient is applied that generates a force, which is large enough to overcome friction. The black arrow in Figure 14 indicates a characteristic stick-slip friction behavior of the microdevice in BSS. In the in vivo experiment the device starts to translate at this critical field gradient (420 mT/m), as illustrated in the figure. Table 1 . The table shows that the translational displacement increases with increasing magnetic gradient, as well as increasing field magnitude.
However, the gradient generally has a larger influence on the translational behavior of the intravitreal microdevice. 
Conclusion
This work demonstrates the general feasibility of controlling the movement of a wireless microdevice inside the eye. As the microrobot can be injected into the eye, steered and removed from the vitreous cavity by a surgeon, this technology potentially offers the possibility to assist in minimally invasive ophthalmic treatments. Future applications include localized slow-release targeted drug delivery and assistance in mechanical operations inside the eye.
Lapine in vivo and porcine ex vivo experiments show that a microdevice can be injected into the vitreous cavity, filled with vitreous, BSS or silicone oil, and moved inside the vitreous cavity.
Rotational as well as translational mobility of the microdevice have been explored. It is shown that the microrobot rotation is similar in the four surrounding media investigated, only being dependent on the rotational frequency of the applied magnetic field. Thus, a surgeon using this technology has better control over the intraocular microrobot at low rotation frequencies and low field magnitudes due to decreased instabilities and magnetic drift. Microrobot translation depends on the applied field gradient and the viscosity and elasticity of the surrounding medium. In the experiments, vitreous exhibits a viscoelastic behavior, and the microdevice can get caught in bundles of collagen fibers, which reveal spring like characteristics. The experiments show that the microrobot has increased translational mobility in cadaver porcine vitreous compared to living lapine vitreous. Reasons for this observation are higher density of rabbit vitreous and the post mortem liquefaction 27 of the vitreous in the cadaver pig eyes.
For future purposes the microrobot can be microfabricated with specific designs. The size as well as the shape of the microrobot can be adjusted to the task. For slow-release targeted drug delivery the microrobot features a drug reservoir, whereas mechanical components, such as needles or hooks, are attached for mechanical applications. The microrobot dimensions are only restricted by the inner diameter of a 23 G needle, which is used for suture-less injection through the pars plana region of the sclera into the eye. The electromagnetic control system, OctoMag, allows for precise control of the microrobot in 3D by generation of an oriented magnetic field and gradient. The risk of ophthalmic surgery can potentially be reduced to a minimum with the assistance of minimally invasive microrobots. Changes in position, which are beyond human perception, can be tracked with high resolution by the surgeon during an operation. Additionally, the forces applied to the robot can be derived from the system inputs. Moreover, the absence of human tremor reduces the risk of damaging the delicate structures in the eye.
Ongoing research focuses on future applications of microrobots inside the eye globe, especially assistance in the treatment of maculopathies, such as AMD, intravenous deployment of anticoagulation agents for RVO and mechanical applications, like epiretinal membrane peeling.
Additionally, we focus on minimally invasive removal of a microrobot and tissue material from the ocular globe. Furthermore, current research addresses the development of coatings to minimize adhesion between the microrobot and collagen fibers in the vitreous. Further studies on the biocompatibility of intravitreal microrobots are currently ongoing.
To summarize, this work investigates microrobots as a tool for minimally invasive intraocular surgery and demonstrates the mobility of a microrobot inside the living eye, surrounded by vitreous, BSS and silicone oil. Rotational as well as translational mobility of the microrobot have been investigated and the potential of an intravitreal microrobot assisting in surgery inside the eye, such as targeted drug delivery or mechanical applications, is examined. Microrobots can augment the capabilities of ophthalmic surgeons and aid them in achieving safer and more precise interventions with reduced recovery times for the patient. As a result, they can be considered a compelling assistive technology for ophthalmic surgery.
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